Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control

Infection Control and Hospital Epidemiology

Volumn 35, Issue 1, 2014, Pages 98-99

  Apisarnthanarak, Anucha ^a   Yang Hsu, Li ^b   Lim, Tze Peng ^b,c   Mundy, Linda M ^d  

^a THAMMASAT UNIVERSITY HOSPITAL   (Thailand)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d LM Mundy LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; HEALTH CARE MANAGEMENT; HUMAN; INFECTION CONTROL; INFORMATION PROCESSING; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ACINETOBACTER BAUMANNII; ANTI-INFECTIVE AGENTS, LOCAL; CARRIER STATE; CHLORHEXIDINE; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH; SKIN;

EID: 84890370053     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/674404     Document Type: Letter

References (10)

1. Batra R, Cooper BS, Whiteley C, Patel AK, Wyncoll D, Edgeworth JD. Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillinresistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis 2010;50:210-217.
2. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099-1106.
3. Vernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166:306-312.
4. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073-2079.
5. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000;21:575-582.
6. Datta R, Platt R, Yokoe DS, Huang SS. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 2011;171:491-494.
7. Dancer SJ, White LF, Lamb J, Girvan EK, Robertson C. Measuring the effect of enhanced cleaning in a UK hospital: a prospective cross-over study. BMC Med 2009;28:28, doi:10.1186 /1741-7015-7-28.
8. Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 2008;46:1121-1122.
9. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Testing: 17th Informational Supplement. Wayne, PA: CLSI, 2010. CLSI document M100-S20.
10. Fuangthong M, Julotok M, Chintana W, Rittiroongrad S, Vattanaviboon P, Mongkolsuk S. Exposure of Acinetobacter baylyi ADP1 to the biocide chlorhexidine leads to acquired resistance to the biocide itself and to oxidants. J Antimicrob Chemother 2011;66:319-322.